Synthesis of composite magnetic nanoparticles Fe₃O₄ with alendronate for osteoporosis treatment

References

• National Osteoporosis Foundation Available from: https://www.nof.org/patients/what-is-osteoporosis/Accessed August 9, 2016
   Google Scholar
• DrakeMTClarkeBLKholsaSBisphosphonates: mechanism of action and role in clinical practiceMayo Clinic Proc200883910321045
   PubMed Web of Science ®Google Scholar
• BoivinGDoublierAFarlayDStrontium ranelate – a promising therapeutic principle in osteoporosisJ Trace Elem Med Biol2012262–315315622565017
   PubMedGoogle Scholar
• SambrookPBirminghamJKellyPPrevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitoninN Engl J Med199332824174717527684512
   PubMedGoogle Scholar
• DempsterDWLambingCLKostenuikPJGrauerARole of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical dataClin Ther201234352153622440513
   PubMed Web of Science ®Google Scholar
• WeinsteinRSRobersonPKManolagasSCGiant osteoclast formation and long-term oral bisphosphonate therapyN Engl J Med200936016536219118304
   PubMedGoogle Scholar
• BurshellALMörickeRCorrea-RotterRCorrelations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronateBone201046493593920060081
   PubMed Web of Science ®Google Scholar
• SatoHTannoKMuro-okaGItaiKSerum ionic fluoride concentrations are significantly decreased after treatment with alendronate in patients with osteoporosisClin Chim Acta201141223–242146214921839730
   PubMedGoogle Scholar
• RossiniMGattiDGirardelloSBragaVJamesGAdamiSEffects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosisBone200027111912210865218
   PubMedGoogle Scholar
• KendlerDKungAWCFuleihanGEHPatients with osteoporosis prefer once weekly to once daily dosing with alendronateMaturitas200448324325115207890
   PubMed Web of Science ®Google Scholar
• LoweCEDepewWTVannerSJPatersonWGMeddingsJBUpper gastrointestinal toxicity of alendronateAm J Gastroenterol200095363464010710050
   PubMedGoogle Scholar
• AbdelmalekMFDouglasDDAlendronate-induced ulcerative esophagitisAm J Gastroenterol1996916128212838651202
   PubMedGoogle Scholar
• JiangWKimBYRutkaJTChanWCAdvances and challenges of nanotechnology-based drug delivery systemsExpert Opin Drug Deliv20074662163317970665
   PubMed Web of Science ®Google Scholar
• WangYZhaoQHanNMesoporous silica nanoparticles in drug delivery and biomedical applicationsNanomedicine201511231332725461284
   PubMed Web of Science ®Google Scholar
• OkaCUshimaruKHoriishiNCore–shell composite particles composed of biodegradable polymer particles and magnetic iron oxide nanoparticles for targeted drug deliveryJ Magn Magn Mater2015381278284
   Web of Science ®Google Scholar
• MassartRPreparation of aqueous magnetic liquids in alkaline and acidic mediaIEEE Trans Magn198117212471248
   Web of Science ®Google Scholar
• XieJLeeSChenXNanoparticle-based theranostic agentsAdv Drug Deliv Rev201062111064107920691229
   PubMed Web of Science ®Google Scholar
• FiguerolaACoratoRDMannaLPellegrinoTFrom iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applicationsPharm Res2010622126143
   Google Scholar
• DaishunLMichaelJHTaeghwanHSurface ligands in synthesis, modification, assembly and biomedical applications of nanoparticlesNano Today201494457477
   Google Scholar
• LewisSLDirksenSRHeitkemperMMBucherLMedical-Surgical Nursing: Assessment and Management of Clinical Problems8th edElsevier Health SciencesAmsterdam, Netherlands2014
   Google Scholar
• JordanAScholzRWustPEffects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivoInt J Hyperthermia19971365876059421741
   PubMed Web of Science ®Google Scholar
• MinamimuraTSatoHKasaokaSTumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in ratsInt J Oncol20001661153115810811989
   PubMed Web of Science ®Google Scholar
• LuAHSalabasELSchüthFMagnetic nanoparticles: synthesis, protection, functionalization, and applicationAngew Chem Int Ed200746812221244
   PubMed Web of Science ®Google Scholar
• BarryMABehnkeCAEastmanAActivation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermiaBiochem Pharmacol19904010235323622244936
   PubMedGoogle Scholar
• VernonCCHandJWFieldSBRadiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trialsInt J Radiat Oncol Biol Phys19963547317448690639
   PubMed Web of Science ®Google Scholar
• ReichelEBerrocalAMIpMTranspupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degenerationOphthalmology1999106101908191410519584
   PubMed Web of Science ®Google Scholar
• JordanAScholzRMaier-HauffKThe effect of thermotherapy using magnetic nanoparticles on rat malignant gliomaJ Neurooncol200678171416314937
   PubMed Web of Science ®Google Scholar
• Maier-HauffKRotheRScholzRIntracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiformeJ Neurooncol2007811536016773216
   PubMed Web of Science ®Google Scholar
• BluteMLTomeraKMHellersteinDKTransurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative StudyJ Urol19931505 Pt 2159115967692092
   PubMedGoogle Scholar
• JordanAMaier-HauffKMagnetic nanoparticles for intracranial thermotherapyJ Nanosci Nanotechnol20077124604460618283851
   PubMed Web of Science ®Google Scholar
• GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical engineeringBiomaterials200526183995402115626447
   PubMed Web of Science ®Google Scholar
• ManolagasSCJilkaRLBone marrow, cytokines, and bone remodeling – emerging insights into the pathophysiology of osteoporosisN Engl J Med199533253053117816067
   PubMed Web of Science ®Google Scholar
• KatagiriTTakahashiNRegulatory mechanisms of osteoblast and osteoclast differentiationOral Dis20028314715912108759
   PubMed Web of Science ®Google Scholar
• KanisJAMeltonLJ3rdChristiansenCJohnstonCCKhaltaevNThe diagnosis of osteoporosisJ Bone Miner Res199498113711417976495
   PubMed Web of Science ®Google Scholar
• LibermanUAWeissSRBröllJEffect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosisN Engl J Med199533322143714447477143
   PubMed Web of Science ®Google Scholar
• BoneHGHoskingDDevogelaerJPTen years’ experience with alendronate for osteoporosis in postmenopausal womenN Engl J Med2004350121189119915028823
   PubMed Web of Science ®Google Scholar
• OrwollEEttingerMWeissSAlendronate for the treatment of osteoporosis in menN Engl J Med2000343960461010979796
   PubMed Web of Science ®Google Scholar
• LeeHLeeEKimDKJangNKJeongYYJonSAntibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imagingJ Am Chem Soc2006128227383738916734494
   PubMed Web of Science ®Google Scholar